KAZAKHSTAN HAS RECEIVED A NEW BATCH OF CHINESE VACCINE SINOPHARM

On January 29, with the assistance of the Embassy of the Republic of Kazakhstan in China, another batch of vaccine against COVID-19 produced by Sinopharm Corporation (VeroCell) arrived from Beijing to Almaty. The cargo included 2 million doses. The delivered doses will make it possible to advance in the completion of the mass vaccination of the population of the Republic of Kazakhstan.

The arrived vaccine, after the completion of the sticker procedure, will be promptly sent to the regions of the country in accordance with the order of the CSEC of the MHRK. And in the coming days, citizens of the Republic of Kazakhstan will be available for vaccination against coronavirus infection.

The anti-covid medicine was developed by the Beijing Institute of Biological Products and approved by WHO this spring, it is recognized in 45 countries around the world. The vaccine is inactivated and two-dose. Shelf life - 24 months.

The single distributor logistics of immunobiological preparations is carried out in compliance with all GMP and GDP standards, as well as the "cold chain".

The peculiarity of the Sinopharm vaccine is that its delivery process does not require a freezer, it is stored and transported at a temperature of plus +2 +8 degrees. Recall that Kazakhstan has already received 4 million doses of the medicine from the Beijing Institute of Biological Products of the Sinopharm company, as well as at the end of April one million doses, released in the UAE under the trade name Hayat-Vax.

Reference:

The vaccine is transported according to the "cold chain" principle - at each stage, strict maintenance of the temperature regime is ensured. At the same time, each level has its own responsible organization.

Transportation of vaccines takes place in 4 stages:

1. From the manufacturer to the hubs of the Single Distributor;

2. From the hubs of the Single Distributor to the warehouses of the regional health departments;

3. From warehouses of regional health departments to medical organizations;

4. Storage in medical organizations before use.